Publications by authors named "E J Vonken"

Purpose: Hepatic Arteriography and C-Arm CT-Guided Ablation of liver tumors (HepACAGA) is a novel technique, combining hepatic-arterial contrast injection with C-arm CT-guided navigation. This study compared the outcomes of the HepACAGA technique with patients treated with conventional ultrasound (US) and/or CT-guided ablation.

Materials And Methods: In this retrospective cohort study, all consecutive patients with hepatocellular carcinoma (HCC) or colorectal liver metastases (CRLM) treated with conventional US-/CT-guided ablation between 1 January 2015, and 31 December 2020, and patients treated with HepACAGA between 1 January 2021, and 31 October 2023, were included.

View Article and Find Full Text PDF
Article Synopsis
  • The POCHET biobank aims to investigate bleeding complications during catheter directed thrombolysis (CDT) for acute limb ischemia (ALI) and to identify potential new biomarkers for predicting these complications, as current reliance on fibrinogen lacks strong evidence.
  • This multicenter prospective project includes patients undergoing CDT, collecting blood samples before and during treatment while assessing bleeding outcomes through a defined protocol.
  • By combining patient data and blood samples, the biobank seeks to advance research on bleeding risks associated with CDT and evaluate various biomarkers, contributing to improved patient care and safety.
View Article and Find Full Text PDF

Purpose: We present a technique that combines Hepatic Arteriography with C-arm CT-Guided Ablation (HepACAGA) to improve tumor visualization, navigation and margin confirmation for percutaneous ablation of liver tumors.

Materials And Methods: All consecutive patients scheduled for HepACAGA between April 20th, 2021, and November 2nd, 2021, were included in this retrospective, cohort study. HepACAGA was performed in an angiography-suite under general anesthesia.

View Article and Find Full Text PDF

Background: The optimal diagnostic and treatment algorithm for patients with suspected thoracic outlet syndrome (TOS) remains challenging. Botulinum toxin (BTX) muscle injections have been suggested to shrink muscles in the thoracic outlet reducing neurovascular compression. This systematic review evaluates the diagnostic and therapeutic value of BTX injections in TOS.

View Article and Find Full Text PDF